SCOPUS 정보 검색 플랫폼

Seminars in Oncology

Volumn 28, Issue 4 SUPPL. 11, 2001, Pages 35-41

Should bisphosphonates be the treatment of choice for metastatic bone disease?

(1) Coleman, Robert E a

a WESTON PARK HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; ZOLEDRONIC ACID;

BONE METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; MORBIDITY; MULTIPLE MYELOMA; OSTEOLYSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0034844861 PISSN: 00937754 EISSN: None Source Type: Journal
DOI: 10.1053/sonc.2001.25427 Document Type: Conference Paper

Times cited : (34)

References (34)

1
- 0033050818
- Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebocontrolled trial
- (1999) J Clin Oncol , vol.17 , pp. 846-854
- Theriault, R.L.¹ Lipton, A.² Hortobagyi, G.N.³

2
- 10544228130
- Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases
- (1996) N Engl J Med , vol.335 , pp. 1785-1791
- Hortobagyi, G.N.¹ Theriault, R.L.² Porter, L.³

3
- 0028859369
- Acid extrusion is induced by osteoclast attachment to bone
- (1995) J Clin Invest , vol.96 , pp. 2277-2283
- Zimola, Z.¹ Wesolowski, G.² Rodan, G.A.³

4
- 0003728024
- New York The Parthenon Publishing Group
- (1997) Bisphosphonates in Bone Disease - From the Laboratory to the Patient (ed 3)
- Fleisch, H.¹

5
- 0024557878
- Palliation of painful bone metastases from prostate cancer using sodium etidronate: Results of a randomised, prospective, double-blind placebo-controlled study
- (1989) J Urol , vol.141 , pp. 85-87
- Smith, J.A.¹

6
- 0025916366
- Effect of daily etidronate on the osteolysis of multiple myeloma
- (1991) J Clin Oncol , vol.9 , pp. 1397-1402
- Belch, A.R.¹ Bergsagel, D.E.² Wilson, K.³

7
- 0034062815
- American Society of Clinical Oncology Guideline on the role of bisphosphonates in breast cancer
- (2000) J Clin Oncol , vol.18 , pp. 1378-1391
- Hillner, B.E.¹ Ingle, J.N.² Berenson, J.R.³

8
- 0035863508
- Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy-A pooled analysis of two randomized, controlled clinical trials
- (2001) J Clin Oncol , vol.19 , pp. 558-567
- Major, P.P.¹ Lortholary, A.² Hon, J.³

9
- 0034214362
- Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases
- (2000) Cancer Res , vol.60 , pp. 2949-2954
- Boissier, S.¹ Ferreras, M.² Peyruchaud, O.³

10
- 0033783227
- Bisphosphonates induce breast cancer cell death in vitro
- (2000) J Bone Miner Res , vol.15 , pp. 2211-2221
- Fromigue, O.¹ Lagneaux, L.² Body, J.J.³

11
- 0035917560
- The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: Evidence for synergy with paclitaxel
- (2001) Br J Cancer , vol.84 , pp. 1126-1134
- Jagdev, S.P.¹ Coleman, R.E.² Shipman, C.M.³

12
- 0034107048
- Bisphosphonates induce apoptosis in human breast cancer cell lines
- (2000) Br J Cancer , vol.82 , pp. 1459-1568
- Seneratne, S.G.¹ Pirianov, G.² Mansi, J.L.³

13
- 0033770704
- Uses and abuses of bisphosphonates
- (1999) Ann Oncol , vol.11 , Issue.SUPPL. 3 , pp. 179-184
- Coleman, R.E.¹

14
- 0031824648
- Pamidronate disodium in the treatment and management of hypercalcaemia
- (1998) Rev Contemp Pharmacother , vol.9 , pp. 147-164
- Coleman, R.E.¹

15
- 0028060450
- High-dose intravenous pamidronate for metastatic bone pain
- (1994) Br J Cancer , vol.70 , pp. 554-558
- Purohit, O.P.¹ Anthony, C.² Radstone, C.R.³

16
- 0026557293
- A doubleblind crossover trial of intravenous clodronate in patients with metastatic bone disease and pain
- (1992) J Pain Symptom Manage , vol.7 , pp. 4-11
- Ernst, D.S.¹ Macdonald, R.N.² Paterson, A.H.³

17
- 0030955855
- A randomised controlled trial of intravenous clodronate in patients with metastatic bone disease and pain
- (1997) J Pain Symptom Manage , vol.13 , pp. 319-326
- Ernst, D.S.¹ Brasher, P.² Hagen, N.³

18
- 0000452803
- Double-blind, placebo-controlled trial of ibandronate breast cancer metastatic to bone
- abstr 2222
- (1999) Proc Am Soc Clin Oncol , vol.18
- Body, J.J.¹ Lichinitser, M.R.² Diehl, I.E.³

19
- 0029782630
- Delay in progression of bone metastases treated with intravenous pamidronate: Results from a multicentre randomised controlled trial
- (1996) J Clin Oncol , vol.14 , pp. 2552-2559
- Conte, P.F.¹ Mauriac, L.² Calabresi, F.³

20
- 0030483518
- Efficacy of pamidronate on skeletal complications from breast cancer metastases. A randomised prospective double blind placebo controlled trial
- Acta Oncol , vol.35 , Issue.SUPPL. 5 , pp. 73-74
- Hultborn, R.¹ Ryden, S.² Gunderson, S.³

21
- 0027531814
- Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer
- (1993) J Clin Oncol , vol.11 , pp. 59-65
- Paterson, A.H.G.¹ Powles, T.J.² Kanis, J.³

22
- 9044219839
- Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma
- (1996) N Engl J Med , vol.334 , pp. 488-493
- Berenson, J.R.¹ Lichtenstein, A.² Porter, L.³

23
- 6844252283
- Longterm pamidronate treatment of advanced multiple myeloma patients reduces skeletal events
- (1998) J Clin Oncol , vol.16 , pp. 593-602
- Berenson, J.R.¹ Lichtenstein, A.M.² Porter, L.³

24
- 0026646339
- Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma
- (1992) Lancet , vol.340 , pp. 1049-1052
- Lahtinen, R.¹ Laakso, M.² Palva, I.³

25
- 0031911183
- A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma
- (1998) Br J Haematol , vol.100 , pp. 317-325
- McCloskey, E.V.¹ MacLennan, I.C.M.² Drayson, M.T.³

26
- 0000311516
- Biochemical markers of malignant bone disease
- Rubens RD, Mundy GR (eds): Cancer and the Skeleton. London, Martin Dunitz
- (2000) , pp. 137-150
- Coleman, R.E.¹

27
- 7144264425
- Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease
- (1997) Ann Oncol , vol.8 , pp. 1243-1250
- Vinholes, J.J.F.¹ Purohit, O.P.² Abbey, M.E.³

28
- 0000846044
- Improvement of bone pain, quality of life and survival time of breast cancer patients with metastatic bone disease treated with intravenous ibandronate
- abstr
- (1999) Eur J Cancer , vol.35 , Issue.SUPPL. 4 , pp. 269
- Diel, I.J.¹ Lichinitser, M.R.² Body, J.J.³

29
- 0003176089
- The Breast Specialty Group of the British Association of Surgical Oncology: The management of metastatic bone disease
- (1999) Eur J Surg Oncol , vol.25 , pp. 3-23

30
- 0032956195
- Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease
- (1999) Ann Oncol , vol.10 , pp. 311-316
- Coleman, R.E.¹ Purohit, O.P.² Black, C.³

31
- 0032880063
- A dose-finding study of zoledronate in hypercalcaemic cancer patients
- (1999) J Bone Miner Res , vol.14 , pp. 1557-1661
- Body, J.J.¹ Lortholary, A.² Romieu, G.³

32
- 0001863523
- Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases: A double-blind, randomised dose response study. Breast Cancer Res Treat 64:
- (2000) , vol.1 , pp. 32
- Berenson, J.¹ Rosen, L.² Howell, A.³

33
- 0003817210
- Phase I open label, dose ranging, safety trial of rapid intravenous zoledronic acid, a novel bisphosphonate, in cancer patients with osteolytic bone metastases
- in press
- Cancer
- Berenson, J.R.¹ Lipton, A.²

34
- 0034984095
- The role of zoledronic acid in cancer: Clinical studies in treatment and prevention of bone metastases
- Semin Oncol , vol.25 , Issue.SUPPL. 6 , pp. 11-16
- Coleman, R.E.¹ Seaman, J.J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.